SUI Group director gets warrants at $5.42–$7.05

SUI Group Holdings Ltd. director Liszt Howard P received a one-time equity grant in the form of four warrant awards, effective July 6, 2026, as part of non-management director compensation.

Rhea-AI Filing Summary

SUI Group Holdings Ltd. director Liszt Howard P received a one-time equity grant in the form of four warrant awards, effective July 6, 2026, as part of non-management director compensation. The grants cover an aggregate of 83,026 underlying common shares at exercise prices between $5.42 and $7.046 per share, with no cash paid for the awards themselves.

The warrants vest in four equal installments: 25% of each tranche becomes exercisable on January 6, 2027, a further 25% on July 6, 2027, another 25% on January 6, 2028, and the final 25% on July 6, 2028. Expiration dates fall in 2031, giving the director several years to choose when to exercise after vesting.

Insider Trade Summary

Grant/Award: 83,026 shares

Grant/Award 4 txns

Insider LISZT HOWARD P

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Warrant for common stock	33,211	$0.00	$0.00
Grant/Award	Warrant for common stock	16,605	$0.00	$0.00
Grant/Award	Warrant for common stock	16,605	$0.00	$0.00
Grant/Award	Warrant for common stock	16,605	$0.00	$0.00

Holdings After Transaction: Warrant for common stock — 83,026 contracts (Direct)

Footnotes (2)

1. F1. Represents a one-time equity grant as part of the Reporting Person's non-management director compensation, effective July 6, 2026.
2. F2. The warrants vest as follows: 25% of each tranche of the warrants become exercisable on January 6, 2027, 25% of each tranche of the warrants will become exercisable on July 6, 2027, 25% of each tranche of the warrants will become exercisable on January 6, 2028, and 25% of each tranche of the warrants will become exercisable on July 6, 2028.

Key Figures

Total underlying shares: 83,026 shares First warrant tranche: 16,605 shares at $7.046 Second warrant tranche: 16,605 shares at $6.504 +5 more

8 metrics

Total underlying shares 83,026 shares Aggregate underlying common stock for all warrant grants effective July 6, 2026

First warrant tranche 16,605 shares at $7.046 Warrant for common stock, exercise price $7.046 per share

Second warrant tranche 16,605 shares at $6.504 Warrant for common stock, exercise price $6.504 per share

Third warrant tranche 16,605 shares at $5.962 Warrant for common stock, exercise price $5.962 per share

Fourth warrant tranche 33,211 shares at $5.42 Largest warrant tranche, exercise price $5.42 per share

Vesting schedule 4 installments of 25% Vests on Jan 6, 2027; Jul 6, 2027; Jan 6, 2028; Jul 6, 2028

Expiration dates 2031 Three tranches expire Jan 6, 2031; one expires Jul 6, 2031

Grant price per warrant $0.00 No cash paid for the warrant grants on award date

Key Terms

Warrant for common stock, non-management director compensation, tranche, vest, +1 more

5 terms

Warrant for common stock financial

"security_title: "Warrant for common stock" for each derivative grant"

non-management director compensation financial

"Represents a one-time equity grant as part of the Reporting Person's non-management director compensation"

tranche financial

"The warrants vest as follows: 25% of each tranche of the warrants become exercisable"

A tranche is one slice of a larger financing or investment that is released, sold, or paid out in separate parts rather than all at once. Investors care because each slice can carry different risk, return and timing—like buying pieces of a cake where some slices are richer or come later—so the specific tranche you hold affects when you get paid and how much you might gain or lose.

vest financial

"The warrants vest as follows: 25% of each tranche of the warrants become exercisable"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

expiration date financial

"expiration_date: "2031-01-06T00:00:00.000Z" and "2031-07-06T00:00:00.000Z""

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/07/2026 - 08:28 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LISZT HOWARD P

(Last) (First) (Middle)

130 LAKE STREET W, SUITE 300

(Street)

WAYZATA MINNESOTA 55391

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
SUI Group Holdings Ltd. [ SUIG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Warrant for common stock	$5.42	07/06/2026		A		33,211(1)		(2)	07/06/2031	Common stock	33,211	$0	33,211	D
Warrant for common stock	$5.962	07/06/2026		A		16,605(1)		(2)	01/06/2031	Common stock	16,605	$0	16,605	D
Warrant for common stock	$6.504	07/06/2026		A		16,605(1)		(2)	01/06/2031	Common stock	16,605	$0	16,605	D
Warrant for common stock	$7.046	07/06/2026		A		16,605(1)		(2)	01/06/2031	Common stock	16,605	$0	16,605	D

Explanation of Responses:

1. Represents a one-time equity grant as part of the Reporting Person's non-management director compensation, effective July 6, 2026.

2. The warrants vest as follows: 25% of each tranche of the warrants become exercisable on January 6, 2027, 25% of each tranche of the warrants will become exercisable on July 6, 2027, 25% of each tranche of the warrants will become exercisable on January 6, 2028, and 25% of each tranche of the warrants will become exercisable on July 6, 2028.

	/s/ Howard P. Liszt	07/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)